Forum Financial Management LP Boosts Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Forum Financial Management LP grew its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,084 shares of the company’s stock after acquiring an additional 314 shares during the period. Forum Financial Management LP’s holdings in GE HealthCare Technologies were worth $571,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the business. Pathway Financial Advisers LLC purchased a new position in shares of GE HealthCare Technologies in the 1st quarter valued at about $25,000. Fred Alger Management LLC purchased a new stake in GE HealthCare Technologies in the 2nd quarter valued at $26,000. M&R Capital Management Inc. purchased a new position in GE HealthCare Technologies during the third quarter worth about $33,000. Elkhorn Partners Limited Partnership acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at $31,000. Finally, ORG Partners LLC increased its position in shares of GE HealthCare Technologies by 2,475.0% during the 2nd quarter. ORG Partners LLC now owns 412 shares of the company’s stock worth $32,000 after purchasing an additional 396 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Up 0.0 %

Shares of NASDAQ:GEHC opened at $86.99 on Tuesday. GE HealthCare Technologies Inc. has a 1-year low of $66.39 and a 1-year high of $94.55. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.82. The stock has a market cap of $39.74 billion, a P/E ratio of 23.90, a P/E/G ratio of 3.25 and a beta of 1.24. The firm has a fifty day moving average price of $88.61 and a 200 day moving average price of $83.42.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, topping analysts’ consensus estimates of $1.06 by $0.08. The business had revenue of $4.86 billion for the quarter, compared to analysts’ expectations of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The business’s revenue for the quarter was up .9% on a year-over-year basis. During the same period in the prior year, the company posted $0.99 EPS. Sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.29 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. The ex-dividend date is Friday, October 18th. GE HealthCare Technologies’s payout ratio is currently 3.30%.

Analysts Set New Price Targets

GEHC has been the subject of several research reports. BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a report on Wednesday, September 18th. Evercore ISI upped their price objective on GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. Stifel Nicolaus raised their target price on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a report on Monday, September 30th. Finally, JPMorgan Chase & Co. initiated coverage on shares of GE HealthCare Technologies in a report on Monday, September 9th. They issued a “neutral” rating and a $90.00 price objective on the stock. One analyst has rated the stock with a sell rating, five have assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $94.36.

Insider Buying and Selling

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the firm’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the transaction, the chief executive officer now owns 17,509 shares of the company’s stock, valued at approximately $1,414,377.02. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.